RecruitingPhase 3NCT04895631
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
Sponsor
Thomas Hope
Enrollment
140 participants
Start Date
Jun 30, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.
Eligibility
Min Age: 13 Years
Inclusion Criteria3
- Age \>= 13 years.
- Biochemically proven hyperparathyroidism and an indication for surgery.
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion Criteria2
- Current Pregnancy.
- Patients unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator to be unsuitable for study participation.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUG18F-Fluorocholine
One-time injection of 4-7 millicurie (mCi)
PROCEDUREPositron emission tomography (PET)
Imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04895631